Colorectal Cancer Coalition

Victory for the FDA

The fate of the FY 08 emergency supplemental appropriations bill in the House was finally decided last night. Leaders on both sides negotiated a deal and came up with a bill that will likely be signed by the President.

The Food and Drug Administration (FDA) was one of the big winners, snagging an additional $150 million. A much lower number than we had hoped for, but a victory nonetheless.

As we mentioned last week, a battle has been going on between Senator Arlen Specter (R-PA) and the Bush Administration. Both have been trying to get the extra $275 million requested by FDA Chief, Andrew Von Eschenbach, but at very different times. The Republican Senator, who has been a champion in the fight for biomedical research dollars, wanted the $275 million added to the emergency supplemental. This would make the money available by early fall of 2008. Meanwhile, the Administration wanted to add the $275 million to the FY 09 budget, not making the funds available until well into next year.

The next step for the bill is to move over to the Senate where it will have to be voted on. This gives an opportunity for the Senate to add even more money to the struggling agency. While we would definitely welcome it, this scenario is likely not to happen.

We will keep you updated on any further developments.

This news article was originally posted on June 20th, 2008 and was accurate at the time of publication. Since then, information may have changed or links may now be outdated. Please call our Answer Line 1-877-427-2111 for the latest information, or talk to your doctor before making any medical decisions.

Posted by Joe Arite on June 20th, 2008
Tags: Bush Administration, Congress, Emergency Supplemental Appropriations bill, FDA

Leave a Comment Comments RSS

Your comments are welcome. However, specific medical advice will not be provided, and we urge you to consult with a qualified physician for diagnosis and for answers to your personal questions. C3 is not responsible for the medical accuracy of any comments left by persons other than C3 staff members. C3 staff members monitor comments and may respond publicly where appropriate.

Please note that we automatically publish the name that you enter next to your post. Also note that our pages are automatically indexed by Google and other search engines, and your name may therefore appear in search results on those sites. So if you wish to remain anonymous please use a different name or enter 'Anon' as the name.

We regret that we are unable to privately answer questions left as comments. So please do not include your phone number, email or mailing address in the body of your comment. For the best personal and direct response to your colorectal cancer treatment questions, please call our Answer Line at 1-877-4CRC-111 (1-877-427-2111).

Name Email (hidden) URL Comments (Basic HTML is allowed - a href, strong, em, blockquote)